MapLight Therapeutics

MapLight Therapeutics

  • Founded: 2018
  • Location: Boston, MA
  • Employee range: 11 - 50
  • Clinical stage: Clin2
  • Therapy area: Autism spectrum disorder¬†
  • Drug types: NEU, PSY
  • Lead product: ML-004
  • Product link:
  • Funding: 10-100M

job board

Short description:


Drug notes:

ML-007 Clin1 dyskinesias. Clin1 schizophrenia; ML-016 RD/Clin0 depression; ML-009 RD/Clin0 hyperactivity/impulsivity; ML-105 RD depression

Long description:

MapLight Therapeutics is developing novel therapeutics for patients with disorders of the central nervous system. Given the complexity of the brain, diseases with highly specific symptoms should be treated with the same therapeutics. MapLight is using the combination of transcriptomics, optogenetics and STARmap to develop a strong pipeline of safe, effective therapeutics. Optogenetics is used to identify key cell types, transcriptomics is to find targets and STARmap is used to visualize neural circuits. MapLight has already brought two novel therapeutics to the clinic, with more on the horizon.


MapLight Therapeutics
Senior Director Corporate Communications
Burlington, MA|6 days ago
MapLight Therapeutics
Accounting Manager
Burlington, MA|8 days ago
MapLight Therapeutics
Senior Clinical Trial Associate
Burlington, MA|16 days ago
MapLight Therapeutics
Clinical Research Associate II / Sr. Clinical Rese...
Burlington, MA|17 days ago
MapLight Therapeutics
Lead Clinical Research Associate
Burlington, MA|21 days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy